Limits...
Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review.

Chen MN, Lin CC, Liu CF - Climacteric (2014)

Bottom Line: Meta-analysis of the seven studies that reported KI data indicated no significant treatment effect of phytoestrogen as compared to placebo (pooled mean difference = 6.44, p = 0.110).Meta-analysis of the ten studies that reported hot flush data indicated that phytoestrogens result in a significantly greater reduction in hot flush frequency compared to placebo (pooled mean difference = 0.89, p < 0.005).Phytoestrogens appear to reduce the frequency of hot flushes in menopausal women, without serious side-effects.

View Article: PubMed Central - PubMed

Affiliation: Hsin Sheng Junior College of Medical Care and Management , Taoyuan.

ABSTRACT

Objective: To perform a meta-analysis examining the efficacy of phytoestrogens for the relief of menopausal symptoms.

Methods: Medline, Cochrane, EMBASE, and Google Scholar databases were searched until September 30, 2013 using the following key words: vasomotor symptoms, menopausal symptoms, phytoestrogens, isoflavones, coumestrol, soy, red clover. Inclusion criteria were (1) randomized controlled trial (RCT), (2) perimenopausal or postmenopausal women experiencing menopausal symptoms, (3) intervention with an oral phytoestrogen. Outcome measures included Kupperman index (KI) changes, daily hot flush frequency, and the likelihood of side-effects.

Results: Of 543 potentially relevant studies identified, 15 RCTs meeting the inclusion criteria were included. The mean age of the subjects ranged from 49 to 58.3 and 48 to 60.1 years, respectively, in the placebo and phytoestrogen groups. The number of participants ranged from 30 to 252, and the intervention periods ranged from 3 to 12 months. Meta-analysis of the seven studies that reported KI data indicated no significant treatment effect of phytoestrogen as compared to placebo (pooled mean difference = 6.44, p = 0.110). Meta-analysis of the ten studies that reported hot flush data indicated that phytoestrogens result in a significantly greater reduction in hot flush frequency compared to placebo (pooled mean difference = 0.89, p < 0.005). Meta-analysis of the five studies that reported side-effect data showed no significant difference between the two groups (p = 0.175).

Conclusion: Phytoestrogens appear to reduce the frequency of hot flushes in menopausal women, without serious side-effects.

Show MeSH

Related in: MedlinePlus

Meta-analysis (a) with sensitivity evaluation (b) for change in Kupperman index between placebo and phytoestrogen groups (seven studies included). The random-effects approach was used due to significant heterogeneity (Q = 370.03, I2 = 98.38, p < 0.001). CI, confidence interval
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4389700&req=5

Figure 2: Meta-analysis (a) with sensitivity evaluation (b) for change in Kupperman index between placebo and phytoestrogen groups (seven studies included). The random-effects approach was used due to significant heterogeneity (Q = 370.03, I2 = 98.38, p < 0.001). CI, confidence interval

Mentions: Of the seven studies that reported KI data17–20,23–25, three reported a significant reduction of KI in the phytoestrogen group when compared with the placebo group17,20,25, while the other four18,19,23,24 reported no difference between the groups. Meta-analysis of the seven studies indicated no significant treatment effect of phytoestrogen when compared to placebo (pooled mean difference = 6.4, p = 0.110, Figure 2a). The pooled estimate remained positive and non-significant after sensitivity analysis based on the leave-one-out approach was made, indicating there was no influence of individual studies on the pooled estimate (Figure 2b).


Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review.

Chen MN, Lin CC, Liu CF - Climacteric (2014)

Meta-analysis (a) with sensitivity evaluation (b) for change in Kupperman index between placebo and phytoestrogen groups (seven studies included). The random-effects approach was used due to significant heterogeneity (Q = 370.03, I2 = 98.38, p < 0.001). CI, confidence interval
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4389700&req=5

Figure 2: Meta-analysis (a) with sensitivity evaluation (b) for change in Kupperman index between placebo and phytoestrogen groups (seven studies included). The random-effects approach was used due to significant heterogeneity (Q = 370.03, I2 = 98.38, p < 0.001). CI, confidence interval
Mentions: Of the seven studies that reported KI data17–20,23–25, three reported a significant reduction of KI in the phytoestrogen group when compared with the placebo group17,20,25, while the other four18,19,23,24 reported no difference between the groups. Meta-analysis of the seven studies indicated no significant treatment effect of phytoestrogen when compared to placebo (pooled mean difference = 6.4, p = 0.110, Figure 2a). The pooled estimate remained positive and non-significant after sensitivity analysis based on the leave-one-out approach was made, indicating there was no influence of individual studies on the pooled estimate (Figure 2b).

Bottom Line: Meta-analysis of the seven studies that reported KI data indicated no significant treatment effect of phytoestrogen as compared to placebo (pooled mean difference = 6.44, p = 0.110).Meta-analysis of the ten studies that reported hot flush data indicated that phytoestrogens result in a significantly greater reduction in hot flush frequency compared to placebo (pooled mean difference = 0.89, p < 0.005).Phytoestrogens appear to reduce the frequency of hot flushes in menopausal women, without serious side-effects.

View Article: PubMed Central - PubMed

Affiliation: Hsin Sheng Junior College of Medical Care and Management , Taoyuan.

ABSTRACT

Objective: To perform a meta-analysis examining the efficacy of phytoestrogens for the relief of menopausal symptoms.

Methods: Medline, Cochrane, EMBASE, and Google Scholar databases were searched until September 30, 2013 using the following key words: vasomotor symptoms, menopausal symptoms, phytoestrogens, isoflavones, coumestrol, soy, red clover. Inclusion criteria were (1) randomized controlled trial (RCT), (2) perimenopausal or postmenopausal women experiencing menopausal symptoms, (3) intervention with an oral phytoestrogen. Outcome measures included Kupperman index (KI) changes, daily hot flush frequency, and the likelihood of side-effects.

Results: Of 543 potentially relevant studies identified, 15 RCTs meeting the inclusion criteria were included. The mean age of the subjects ranged from 49 to 58.3 and 48 to 60.1 years, respectively, in the placebo and phytoestrogen groups. The number of participants ranged from 30 to 252, and the intervention periods ranged from 3 to 12 months. Meta-analysis of the seven studies that reported KI data indicated no significant treatment effect of phytoestrogen as compared to placebo (pooled mean difference = 6.44, p = 0.110). Meta-analysis of the ten studies that reported hot flush data indicated that phytoestrogens result in a significantly greater reduction in hot flush frequency compared to placebo (pooled mean difference = 0.89, p < 0.005). Meta-analysis of the five studies that reported side-effect data showed no significant difference between the two groups (p = 0.175).

Conclusion: Phytoestrogens appear to reduce the frequency of hot flushes in menopausal women, without serious side-effects.

Show MeSH
Related in: MedlinePlus